Microfluidic fabrication of cationic curcumin nanoparticles as an anti-cancer agent.

Curcumin nanoparticles of less than 50 nm in diameter are accessible using a continuous flow microfluidic rotating tube processor (RTP) under scalable conditions, at room temperature. A mixture of DDAB and Pluronic F127 renders higher stability of the curcumin nanoparticles in physiological pH 7.4 for up to eight hours. The nanoparticles have enhanced cytotoxicity in estrogens receptor negative and positive breast cancer cell lines compared with free curcumin.

[1]  R. Donehower,et al.  Peripheral neuropathy from taxol and cisplatin combination chemotherapy: Clinical and electrophysiological studies , 1994, Annals of neurology.

[2]  P. Pizzo,et al.  Grp94 acts as a mediator of curcumin-induced antioxidant defence in myogenic cells , 2010, Journal of Cellular and Molecular Medicine.

[3]  T. Osawa,et al.  Involvement of the beta-diketone moiety in the antioxidative mechanism of tetrahydrocurcumin. , 1996, Biochemical pharmacology.

[4]  R. Srimal,et al.  Pharmacology of diferuloyl methane (curcumin), a non‐steroidal anti‐inflammatory agent * , 1973, The Journal of pharmacy and pharmacology.

[5]  U. Bandyopadhyay,et al.  Turmeric and curcumin: Biological actions and medicinal applications , 2004 .

[6]  E. Perez.  Impact, mechanisms, and novel chemotherapy strategies for overcoming resistance to anthracyclines and taxanes in metastatic breast cancer , 2009, Breast Cancer Research and Treatment.

[7]  Tak W. Kee,et al.  The role of charge in the surfactant-assisted stabilization of the natural product curcumin. , 2010, Langmuir : the ACS journal of surfaces and colloids.

[8]  Murali M. Yallapu,et al.  Fabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cells. , 2010, Journal of colloid and interface science.

[9]  D. H. Napper,et al.  Studies of the steric stabilization of colloidal particles , 1971 .

[10]  Thorsteinn Loftsson,et al.  Studies of curcumin and curcuminoids. XXVII. Cyclodextrin complexation: solubility, chemical and photochemical stability. , 2002, International journal of pharmaceutics.

[11]  H. Ammon,et al.  Pharmacology of Curcuma longa , 1991, Planta medica.

[12]  K. Shinoda,et al.  Solution behavior of dialkyldimethylammonium chloride in water. Basic properties of antistatic fabric softeners , 1978 .

[13]  P. Steeg.  Tumor metastasis: mechanistic insights and clinical challenges , 2006, Nature Medicine.

[14]  J. Vishwanatha,et al.  Formulation, characterization and evaluation of curcumin-loaded PLGA nanospheres for cancer therapy. , 2009, Anticancer research.

[15]  Bharat B. Aggarwal,et al.  Epigenetic changes induced by curcumin and other natural compounds , 2011, Genes & Nutrition.

[16]  G. Mazzanti,et al.  Hepatotoxicity from green tea: a review of the literature and two unpublished cases , 2009, European Journal of Clinical Pharmacology.

[17]  Jen-kun Lin,et al.  Stability of curcumin in buffer solutions and characterization of its degradation products. , 1997, Journal of pharmaceutical and biomedical analysis.

[18]  Y. Surh,et al.  Curcumin exerts antidifferentiation effect through AMPKalpha-PPAR-gamma in 3T3-L1 adipocytes and antiproliferatory effect through AMPKalpha-COX-2 in cancer cells. , 2009, Journal of agricultural and food chemistry.

[19]  J. Greif,et al.  Inhibition of pancreatic and lung adenocarcinoma cell survival by curcumin is associated with increased apoptosis, down-regulation of COX-2 and EGFR and inhibition of Erk1/2 activity. , 2006, Anticancer research.

[20]  E. Srivatsan,et al.  Liposome-Encapsulated Curcumin Suppresses Growth of Head and Neck Squamous Cell Carcinoma In vitro and in Xenografts through the Inhibition of Nuclear Factor κB by an AKT-Independent Pathway , 2008, Clinical Cancer Research.

[21]  R. Planalp,et al.  Curcumin: From ancient medicine to current clinical trials , 2008, Cellular and Molecular Life Sciences.

[22]  B. Escudier,et al.  5-Fluorouracil cardiotoxicity: a unique mechanism for ischaemic cardiopathy and cardiac failure? , 1996, European journal of cancer.

[23]  Li Jiang,et al.  MicroRNA-148b is frequently down-regulated in gastric cancer and acts as a tumor suppressor by inhibiting cell proliferation , 2011, Molecular Cancer.

[24]  B. Aggarwal,et al.  Anticancer potential of curcumin: preclinical and clinical studies. , 2003, Anticancer research.

[25]  K. Pienta,et al.  Inhibition of prostate specific antigen expression by genistein in prostate cancer cells. , 2000, International journal of oncology.

[26]  Murali M. Yallapu,et al.  Poly(β-cyclodextrin)/curcumin self-assembly: a novel approach to improve curcumin delivery and its therapeutic efficacy in prostate cancer cells. , 2010, Macromolecular bioscience.

[27]  F. Sarkar,et al.  Expression of prostate‐specific antigen is transcriptionally regulated by genistein in prostate cancer cells , 2002, Molecular carcinogenesis.

[28]  W. Jordan,et al.  Curcumin--a natural herb with anti-HIV activity. , 1996, Journal of the National Medical Association.

[29]  B. Aggarwal,et al.  Curcumin: the Indian solid gold. , 2007, Advances in experimental medicine and biology.

[30]  G. Mahady,et al.  Turmeric (Curcuma longa) and curcumin inhibit the growth of Helicobacter pylori, a group 1 carcinogen. , 2002, Anticancer research.

[31]  Hoi-Seon Lee,et al.  Fungicidal property of Curcuma longa L. rhizome-derived curcumin against phytopathogenic fungi in a greenhouse. , 2003, Journal of agricultural and food chemistry.

[32]  S. Jee,et al.  Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. , 2001, Anticancer research.

[33]  Robert A Newman,et al.  Bioavailability of curcumin: problems and promises. , 2007, Molecular pharmaceutics.

[34]  W. Saltzman,et al.  Partial correction of cystic fibrosis defects with PLGA nanoparticles encapsulating curcumin. , 2010, Molecular pharmaceutics.

[35]  R. Liu,et al.  Effect of selected phytochemicals and apple extracts on NF-kappaB activation in human breast cancer MCF-7 cells. , 2007, Journal of agricultural and food chemistry.

[36]  L. Leon,et al.  Biological activities of Curcuma longa L. , 2001, Memorias do Instituto Oswaldo Cruz.

[37]  R. Kuttan,et al.  Potential anticancer activity of turmeric (Curcuma longa). , 1985, Cancer letters.

[38]  B. Aggarwal,et al.  Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. , 2008, Cancer letters.

[39]  B. Aggarwal,et al.  Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. , 2009, The international journal of biochemistry & cell biology.

[40]  C. Orlandini,et al.  Cardiotoxicity of epirubicin/paclitaxel-containing regimens: role of cardiac risk factors. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[41]  A. Safavy,et al.  Design and development of water-soluble curcumin conjugates as potential anticancer agents. , 2007, Journal of medicinal chemistry.